Prevalence of Sexually Transmitted Infections (STIs) Into Prison in Reunion (PRECARIST)

Prevalence of Sexually Transmitted Infections (STIs) at Entry Into Prison in Reunion

Since the beginning of the 2000s, there has been a steady increase in the incidence of STIs in France. In Reunion, the few figures available seem to show the same phenomenon, especially for syphilis. The unfavorable socio-economic context, which is characterized by high levels of precariousness, significant population exchanges (immigration, travel) with neighboring countries, behaviors around sexuality or screening for STIs different from those observed in mainland France are all factors testify to the singularity of the Reunion island in relation to the metropolitan France with regard to the risk factors of STIs.

STI management has become a priority in public health; in particular, the 2010-2014 HIV and STI control plan emphasized the need for their surveillance and screening. These are often asymptomatic infections that can cause serious complications if they are not treated (infertility, ectopic pregnancies, maternal-fetal infections, ...). Screening them in at-risk populations is therefore essential to reduce their prevalence.

The prison population is a vulnerable population, possibly exposed during the incarceration but also upstream of it (generally low levels of education, over-represented disadvantaged social categories, low access and use of care, high prevalence of risky behaviors). ). Some prevalence studies of STIs in these populations have been carried out in metropolitan France, indicating a prevalence higher than that observed in the general population. There is little data on the subject for the prison population in Réunion; Given the local specificities, it seems necessary to improve the epidemiological knowledge of STIs in this prison population in Réunion, in order to be able to adapt the prevention and care measures, the conditions of detention presenting potentially aggravating situations (promiscuity, confinement). , hygienic conditions, ...).

Study Overview

• Status: Completed
• Conditions: Sexually Transmitted Diseases

• Study Type: Observational
• Enrollment (Actual): 700

Contacts and Locations

Study Locations

• Réunion
  • Saint-Denis, Réunion, 97400
    • Centre hospitalier universitaire de la Réunion

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Screening will be offered to all adults entering prison at Domenjod prison (Reunion Island) between 01/02/2018 and 30/04/2019.

Description

Inclusion Criteria:

• imprisoned at Domenjod prison between 01/02/2018 and on 04/30/2019
• able to answer a questionnaire,
• domiciled in Réunion at the time of incarceration,
• incarceration medical examination carried out within 7 days incarceration,

Exclusion Criteria:

• incarcerated by transfer from another penal institution
• having had antibiotic therapy in the 3 months before the inclusion consultation.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of Sexually Transmitted Infection with Chlamydia trachomatis, Neisseria gonorrheae and Mycoplasma genitalium	Proportion of people with a positive triplex Polymerase Chain Reaction result of detection of Chlamydia trachomatis, Neisseria gonorrheae and/or Mycoplasma genitalium on samples.	Day 1

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de la Réunion
• Investigators: Principal Investigator: Marie-Pierre MOITON, MD, CHU de la Réunion

Study record dates

Study Major Dates

• Study Start (ACTUAL): June 19, 2018
• Primary Completion (ACTUAL): September 18, 2019
• Study Completion (ACTUAL): September 30, 2019

Study Registration Dates

• First Submitted: October 27, 2020
• First Submitted That Met QC Criteria: October 27, 2020
• First Posted (ACTUAL): November 2, 2020

Study Record Updates

• Last Update Posted (ACTUAL): November 2, 2020
• Last Update Submitted That Met QC Criteria: October 27, 2020
• Last Verified: October 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Infections; Communicable Diseases; Disease Attributes; Sexually Transmitted Diseases
• Other Study ID Numbers: 2016/CHU/11

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No